FDA Approves New Bladder Cancer First-Line Standard of Care.

Published Date: 18 Dec 2023

In comparison to chemotherapy, the combination of pembrolizumab and enfortumab vedotin doubled survival.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

2.

New Gene Therapy Nears EU Nod for Bladder Cancer

3.

Too Many Chest CTs for Incidental Lung Nodules?

4.

In cancer patients taking immune checkpoint inhibitors, systematic vitamin D supplementation improves outcomes.

5.

FDA Approves New Bladder Cancer First-Line Standard of Care.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot